Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia

Clinical trial NCT06075940 · RECRUITING

Trial details

NCT number: NCT06075940
Sponsor: R3 Vascular Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Critical Limb-Threatening Ischemia Critical Limb Ischemia Critical Lower Limb Ischemia

Start date: 2024-03-04
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.